
    
      In a random, placebo controlled, double blind study, collagenase injection therapy will be
      investigated for it's ability to disrupt the Dupuytren's cord.

      Resultant cord disruption may obviate the need for patients to have surgery to correct the
      finger flexion contractures of Dupuytren's disease.
    
  